Difference between revisions of "Ultrasound CEUS BC"
Jump to navigation
Jump to search
| (67 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
| − | :Co-chairs: Michalakis (Mike) A. Averkiou, PhD; Richard G. Barr, MD, PhD | + | :Co-chairs: Michalakis (Mike) A. Averkiou, PhD; Richard G. Barr, MD, PhD; Todd Erpelding, PhD, MSE |
| − | : | + | :RSNA Staff Support: Julie Lisiecki |
* [http://tinyurl.com/QIBA-CEUS-Roster Roster] | * [http://tinyurl.com/QIBA-CEUS-Roster Roster] | ||
| + | |||
==Project Snapshot== | ==Project Snapshot== | ||
| Line 13: | Line 14: | ||
'''CEUS Biomarker Committee Proposal:''' | '''CEUS Biomarker Committee Proposal:''' | ||
*[[Media:QIBA Committee for Quantitative Contrast Enhanced Ultrasound_Final.pdf | QIBA CEUS Biomarker Committee Proposal]] | *[[Media:QIBA Committee for Quantitative Contrast Enhanced Ultrasound_Final.pdf | QIBA CEUS Biomarker Committee Proposal]] | ||
| + | |||
==Recent Meetings== | ==Recent Meetings== | ||
'''Approved Call Summaries:''' | '''Approved Call Summaries:''' | ||
| − | *[[Media: | + | *[[Media:05 12 2023 QIBA CEUS BC Call Summary-FINAL-MA.pdf|May 12, 2023]] |
| − | *[[Media: | + | *[[Media:04 14 2023 QIBA CEUS BC Call Summary-FINAL.pdf|April 14, 2023]] |
| − | *[[Media: | + | *[[Media:03 10 2023 QIBA CEUS BC Call Summary-FINAL-MA.pdf|March 10, 2023]] |
| + | *[[Media:02 10 2023 QIBA CEUS BC Call Summary-FINAL.pdf|February 10, 2023]] | ||
| + | *[[Media:01 13 2023 QIBA CEUS BC Call Summary-FINAL.pdf|January 13, 2023]] | ||
| + | *[[Media:12 09 2022 QIBA CEUS BC Call Summary-FINAL.pdf|December 9, 2022]] | ||
| + | *No calls in October or November | ||
| + | *[[Media:09 09 2022 QIBA CEUS BC Call Summary-FINAL.pdf|September 9, 2022]] | ||
| + | *[[Media:08 12 2022 QIBA CEUS BC Call Summary-FINAL-2.pdf|August 12, 2022]] | ||
| + | *[[Media:07 15 2022 QIBA CEUS BC Call Summary-FINAL.pdf|July 15, 2022]] | ||
| + | *[[Media:06 10 2022 QIBA CEUS BC Call Summary-FINAL.pdf|June 10, 2022]] | ||
| + | *[[Media:05 13 2022 QIBA CEUS BC Call Summary-FINAL.pdf|May 13, 2022]] | ||
| + | *[[Media:03 11 2022 QIBA CEUS BC Call Summary-FINAL.pdf|March 11, 2022]] | ||
| + | *[[Media:02 11 2022 QIBA CEUS BC Call Summary-FINAL.pdf|February 11, 2022]] | ||
| + | *[[Media:01 14 2022 QIBA CEUS BC Call Summary-FINAL.pdf|January 14, 2022]] | ||
| − | |||
'''''[[US CEUS Call Summary Archive]]''''' | '''''[[US CEUS Call Summary Archive]]''''' | ||
| + | [[CEUS Task Force (TF) Call Summaries]] | ||
==Working Documents== | ==Working Documents== | ||
| Line 31: | Line 45: | ||
==Statistical Reference Documents== | ==Statistical Reference Documents== | ||
| − | |||
==Workflow Documents== | ==Workflow Documents== | ||
Latest revision as of 21:38, 16 May 2023
- Co-chairs: Michalakis (Mike) A. Averkiou, PhD; Richard G. Barr, MD, PhD; Todd Erpelding, PhD, MSE
- RSNA Staff Support: Julie Lisiecki
Project Snapshot
The Contrast Enhanced Ultrasound Biomarker Committee (CEUS BC) seeks to develop a quantitative imaging profile for CEUS imaging.
Project Descriptions:
CEUS Biomarker Committee Proposal:
Recent Meetings
Approved Call Summaries:
- December 9, 2022
- No calls in October or November
- September 9, 2022
- August 12, 2022
- July 15, 2022
- June 10, 2022
- May 13, 2022
- March 11, 2022
- February 11, 2022
- January 14, 2022
CEUS Task Force (TF) Call Summaries
Working Documents
Statistical Reference Documents
Workflow Documents
Historical Background - Formation of the Group
Reference Materials
Original Proposal to the QIBA Steering Committee:
Vendor Press Release:
Presentations: